Last week a study showing that immunotherapies may lead to rapid tumor growth in a small subset of patients met with some concern among oncologists and researchers. They worried that the news could dampen enthusiasm surrounding cancer’s most promising new therapy.
Indeed, some of the researchers who observed the effect expressed hesitancy about sharing the news widely.
This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.
We’re not God. But some stupid guys always try to act like God.